⌘K

16:07:03·1631d

SECFilingvia Quantisnow

Acumen Pharmaceuticals Inc. filed SEC Form 8-K: Leadership Update

ByQuantisnow·Wall Street's wire, on your screen.

ABOS· Acumen Pharmaceuticals Inc.

Health Care

Original source

Quantisnowquantisnow.com

Quantisnow streams SEC filings, FDA approvals, analyst ratings, insider trades, and press releases to retail investors in real time. This insight was curated and delivered from the Quantisnow live feed.

Related

Director Porter Derrell exercised 19,500 shares at a strike of $1.07 and sold $75,240 worth of shares (32,300 units at $2.33), decreasing direct ownership by 27% to 35,500 units (SEC Form 4)
SEC Form 144 filed by Acumen Pharmaceuticals Inc.
Acumen Pharmaceuticals Inc. filed SEC Form 8-K: Regulation FD Disclosure, Other Events, Financial Statements and Exhibits
Director Fountain Nathan B sold $14,273 worth of shares (6,400 units at $2.23), decreasing direct ownership by 12% to 48,150 units (SEC Form 4)
Director Ra Capital Management, L.P. was granted 35,500 shares (SEC Form 4)

Acumen Pharmaceuticals Inc. filed SEC Form 8-K: Leadership Update | Quantisnow